Acorda Therapeutics Inc. | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Acorda Therapeutics Inc.

An SI Board Since October 2003

Posts	SubjectMarks	Bans	Symbol
120	6	0	ACOR

Emcee: michael_f_murphy	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
45	My wife's neuro (BG) said she expects it to be approved shortly. BG is a gr	IRWIN JAMES FRANKEL	-	9/2/2009
44	Advisory meeting Oct 14, 2009. That was close. I was starting to worry about m	kenhott	-	8/25/2009
43	Yes I did, and their explanations made sense to me.	idos	-	8/5/2009
42	Acorda Therapeutics Names Ruhi Kahn as Vice President, Business Development Last	kenhott	-	8/5/2009
41	The fear is that somehow the drug is making the disease progress with LT use. I	kenhott	-	8/5/2009
40	Sounds like you listened to the CC also. From the CC, I didn't hear anythin	kenhott	-	8/5/2009
39	Ken, Maybe I don't understand the ACOR drug ..it was my understanding the dr	Arthur Radley	-	8/4/2009
38	Importantly, these "relapses" improved when patient went back on fampr	idos	-	8/4/2009
37	From the CC, these "relapses" are a mix bag of different things that t	kenhott	1	8/4/2009
36	Meanwhile, the company reported updated side-effect information from the Famprid	Arthur Radley	-	8/4/2009
35	Man, still no love for ACOR. Acorda Therapeutics Reports Second Quarter 2009 Fi	kenhott	1	8/4/2009
34	BIOGEN IN PARTNERSHIP WITH ACORDA..Great for MS patients.	mlkr	-	7/1/2009
33	What? No love for ACOR?? People wanted a buyout, I guess. --------------------	kenhott	-	7/1/2009
32	Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Applicati	kenhott	-	5/6/2009
31	Well, I don't find his arguments all that compelling. His problems... (1)	kenhott	-	5/4/2009
30	Ken, There is some validity to this article........however, I do hope that the F	Arthur Radley	-	4/24/2009
29	23ish days between getting the RTF letter and putting in the reply to the FDA.	kenhott	-	4/23/2009
28	Acorda announced that it has resubmitted its NDA for Fampridine-SR.	idos	-	4/23/2009
27	I actually read my own post this time. <Minor problems with formatting, etc.	kenhott	-	4/3/2009
26	Ken, There should be no excuse for a biotech company to screw up the filing form	Arthur Radley	-	4/2/2009
25	I see my previous post was, as usual, up to my personal high standards. A new d	kenhott	-	4/2/2009
24	finance.yahoo.com	Arthur Radley	-	4/1/2009
23	<reply>	kenhott	-	4/1/2009
22	Acorda Therapeutics Receives Refuse to File Letter from FDA on Fampridine-SR NDA	kenhott	1	3/31/2009
21	Hapoalim Securities Initiates Coverage on Acorda Therapeutics (ACOR) with a Mark	Arthur Radley	-	3/24/2009

Go to reply# or date (mm/dd/yy):